Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience
{{output}}
Purpose Capecitabine is widely used as a single agent on a 21-day cycle in the management of metastatic breast cancer (MBC). Our primary objective was to compare the standard dosing of capecitabine (Arm A: days 1-14 on 21-day cycle) to biweekly dosing (Arm B: ... ...
